Sandoz OTC South Africa

Sandoz OTC South Africa For this reason, we want to make sure that the discussions that take place on the timeline stay on topic and are constructive.

Sandoz, a division of Novartis, is committed to pioneering access for patients and, in doing so, to playing a leading role in supporting the growing healthcare needs of today’s society Sandoz Facebook Community Guidelines

We welcome the opportunity to hear from you and would like to share some simple ‘house rules’ to help everybody get the best from the community. We work in regulated industries and because of the unique legal situation in the healthcare space, we can't engage in sensitive topics, or discussion(s) about products - ours or other companies' - or treatment options on this page. If your comment doesn't comply with the following basic rules, it may be delayed, or in some cases, not be published:
• If your posts are product related
• If your posts include profanity, defamatory, libelous, offensive, abusive, discriminatory or demeaning content (including images, videos and links);
• If your posts are disparaging, threatening, condone violence or illegal behavior;
• If your posts are off-topic;
• If your posts offer health or medical advice;
• If your posts contain any personal information e.g. names of individuals, email address or phone number;
• If your posts violate another's copyright or intellectual property;
• If your posts are commercial, e.g. sells products and services, or recruit fans and followers;
• If your posts are excessively repetitive and/or disruptive to the community or are spam;
• If your posts contain proprietary, confidential, sensitive, or nonpublic information;
• If your posts don't follow Facebook's posting guidelines and Terms of Use. Please be aware that fans who continuously and repeatedly contravene the above rules may be removed from our fan list. In this case the user would no longer be able to follow our news, comment on our posts, or send us messages. This community is English speaking only and as such any non-English language content will be removed. Medical side effects or adverse events

If you believe that you have experienced any medical side effects or reactions from a Novartis product, you should consult your physician, pharmacist or other healthcare professional immediately. You can also report these to us directly by visiting https://www.report.novartis.com/. We suggest sharing as little personal information as possible on the page, especially sharing any specific data concerning your personal health should be avoided. Please note that we will delete any comments including special category of personal data (i.e. health data, criminal records, genetic data, biometric data, religious beliefs, data regarding s*x life) as soon as seen. Should you, however, decide to include a post detailing any side effects, Novartis may need to contact you to find out more information. Posts of this nature may not appear or may need to be removed from our page; this is due to legal obligations concerning drug safety reporting. Storing and using private information

Content you share in this channel is available to the public. Novartis may process, store and use information you chose to share through this channel for reasons such as improving its products and services, reporting adverse events or providing you with assistance upon your request or for any other related legal obligations. To facilitate requests, we may ask for additional information which will only be used for the purpose it was initially collected. In case of an adverse event or product issue you report to us, we will need to store and use identifying information you provide in accordance with the applicable local laws. This information is required to be transferred abroad which will be submitted to the Novartis Drug Safety department and/or regulatory authorities. In such case, we are also required to store your personal data to comply with legal and regulatory requirements/obligations. If you share personal information relating to other people, you represent that you have the authority to lawfully do so and to permit us to use the information. Please kindly note that we may use 3rd party service providers to help us manage your comments and direct messages which means that they too would have access to any personal information you share with us. Such 3rd party service providers are contractually bound to ensure an adequate protection and security of your personal information. Note that the 3rd party service providers might transfer your personal information to other jurisdictions than yours with all necessary adequate protection in order to ensure the security. Please note that Facebook also has access to information you share with us through their platform. Novartis shall not be responsible on how Facebook uses, processes, retains your information. For more details read the Facebook Privacy Policy. For additional information about privacy at Novartis, read our Privacy Policy. Thank you for reading and being a part of the community.

Address

Sandoz South Africa (Pty) Ltd. The Novartis Building. Magwa Crescent West. Waterfall City. Jukskei View
Johannesburg
2090

Opening Hours

Monday 08:30 - 17:00
Tuesday 08:30 - 17:00
Wednesday 08:30 - 17:00
Thursday 08:30 - 17:00
Friday 08:30 - 17:00

Telephone

+27113476600

Products

[S1] ACC® 200 (effervescent tablets); Reg No.: 29/10.2.2/0753. COMPOSITION: Each effervescent tablet contains: 200 mg Acetylcysteine. PHARMACOLOGICAL CLASSIFICATION: A 10.3. Medicines acting on the respiratory system – other. For more information visit: www.acc200.co.za

[S1] TERBANE® 10 mg (cream); Reg. No.: A39/20.2.2/0009. COMPOSITION: Each 1 g Terbane cream contains 10 mg terbinafine hydrochloride; 1,0 % m/m benzyl alcohol (preservative). PHARMACOLOGICAL CLASSIFICATION: A 20.2.2. Antimicrobial (chemotherapeutic) agents. Fungicides. For more information visit: www.terbane.co.za

NOTE: For full prescribing information, refer to the package insert approved by the South African Health Products Regulatory Authority (SAHPRA).

Sandoz SA (Pty) Ltd, Reg. No. 1990/001979/07. The Novartis Building, Magwa Crescent West, Waterfall City, Jukskei View, Gauteng, 2090. Tel: +27 (11) 347 6600. SANCAL Customer Call Centre: +27 (0)861 726 225. ZA2106014562

Alerts

Be the first to know and let us send you an email when Sandoz OTC South Africa posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Sandoz OTC South Africa:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram